68-5
96/120

546moto S, Takahashi R, Hattori N, Ikeda A: Electrical cortical stimulations modulate spike and post-spike slow-related high-frequency activities in human epileptic foci. Clin Neuro‑physiol, 2020; 131: 1741-1754. doi: 10.1016/j.clinph.2020.03.042. 59) Nishida Y, Takahashi YK, Kanai T, Nose Y, Ishibashi S, Sanjo N, Uzawa A, Oda F, Ozawa Y, Kuwabara S, Noguchi E, Suzuki S, Naka‑hara J, Suzuki N, Ogawa T, Yokoyama K, Hattori N, Konno S, Fujioka T, Kawaguchi N, Hatanaka Y, Sonoo M, Kaneko J, Ogino M, Nishiyama K, Nomura K, Yokota T: Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis. Eur J Neurol, 2020; 27: 100-104. doi:10.1111/ene.14039. 60) Nishikawa N, Iwaki H, Shiraishi T, Mukai Y, Takahashi Y, Murata M: Female, aging, difference formulations of DCI, or lower body weight increases AUC4hr of levodopa in patients with Parkinson’s disease. Parkin‑sonism Relat Disord, 2020; 76: 16-20. 61) Nishioka K, Hashizume Y, Takanashi M, Daida K, Li Y, Yoshino H, Tambasco N, Prontera P, Hattori Y, Ueda A, Watanabe H, Hattori N: Pathological findings in a patient with alpha- synuclein p.A53T and familial Parkinson’s disease. Parkinsonism Relat Disord, 2020; 81: 183-187. doi:10.1016/j.parkreldis.2020.11.001. 62) Noda K, Ando M, Jo T, Hattori A, Ogaki K, Sugiyama M, Hattori N, Okuma Y: Mesial Frontal Lobe Infarction Presenting as Pisa Syndrome. J Stroke Cerebrovasc Dis, 2020; 29: 104882. doi: 10.1016/j.jstrokecerebrovasdis. 2020.104882. 63) Noda S, Sato S, Fukuda T, Tada N, Uchiyama Y, Tanaka K, Hattori N: Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice. Neurobiol Dis, 2020; 136: 104717. doi: 10.1016/j.nbd.2019.104717. 64) Noda S, Sato S, Fukuda T, Tada N, Hattori N: Aging-related motor function and dopami‑nergic neuronal loss in C57BL/6 mice. Mol Brain, 2020; 13: 46. doi: 10.1186/s13041-020-00585-6. 65) Noda S, Sato S, Fukuda T, Tada N, Uchiyama Y, Tanaka K, Hattori N: Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice. Neurobiol Dis, 2020; 136: 104717. doi: 10.1016/j.nbd.2019.104717. 66) Ogawa T, Hatano T, Oyama G, Takanashi M, Taniguchi D, Hattori N: Graphic Summary of Movement Disorders Society Criteria for Progressive Supranuclear Palsy and Multiple Allocations eXtinction Rules. Mov Disord Clin Pract, 2020; 7: 240-242. doi: 10.1002/mdc3. 12894. eCollection 2020 Feb. PubMed PMID: 32071951 67) Ogawa T, Ogaki K, Ishiguro M, Ando M, Yoshida T, Noda K, Hattori N, Okuma Y: Novel GFAP p. Glu206Ala Mutation in Alex‑ander Disease with Decreased Dopamine Transporter Uptake. Mov Disord Clin Pract, 2020; 7: 720-722. doi: 10.1002/mdc3.12998. 68) Oji Y, Hatano T, Ueno SI, Funayama M, Ishi‑kawa KI, Okuzumi A, Noda S, Sato S, Satake W, Toda T, Li Y, Hino-Takai T, Kakuta S, Tsunemi T, Yoshino H, Nishioka K, Hattori T, Mizutani Y, Mutoh T, Yokochi F, Ichinose Y, Koh K, Shindo K, Takiyama Y, Hamaguchi T, Yamada M, Farrer MJ, Uchiyama Y, Akamatsu W, Wu YR, Matsuda J, Hattori N: Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease. Brain, 2020; 143: 1190-1205, doi: 10.1093/brain/awaa064 69) Oyama M, Okada K, Masuda M, Shimizu Y, Yokoyama K, Uzawa A, Kawaguchi N, Ikeguchi R, Hoshino Y, Hatano T, Ozawa Y, Nakahara J, Aizawa H, Kitagawa K, Hattori N, Kuwa‑bara S, Murai H, Suzuki S: Suitable indica‑tions of eculizumab for patients with refrac‑tory generalized myasthenia gravis. Ther Adv Neurol Disord, 2020; 13: 1756286420904207. doi: 10.1177/1756286420904207. 70) Saccenti L, Hagiwara A, Andica C, Yokoyama K, Fujita S, Kato S, Maekawa T, Kamagata K, Le Berre A, Hori M, Wada A, Tateishi U, Hattori N, Aoki S: Myelin Measurement Using Quantitative Magnetic Resonance Imaging: A Correlation Study Comparing Various Imaging Techniques in Patients with Multiple Sclerosis. Cells, 2020; 9: 393. doi: 10.3390/cells 9020393. 71) Sato S, Noda S, Hattori N: Pathogenic insights to Parkin-linked model mice. Neurosci Res,

元のページ  ../index.html#96

このブックを見る